Deutsche Telekom’s subsidiary, MMS, has taken a bold step into the blockchain world by becoming a validator for Injective, an interoperable Layer-1 blockchain. This move strengthens Injective’s network security and decentralization. It also marks another milestone in Deutsche Telekom’s growing Web3 presence. This collaboration showcases a blend of traditional enterprise and cutting-edge blockchain technology. Securing the reliability of the Injective Network Injective revealed the partnership on X with excitement, highlighting how MMS will help operate and secure the network. Injective 🥷 @injective · Follow Today, Deutsche Telekom MMS joins Injective’s validator set.This collaboration bridges traditional enterprise with blockchain tech, reinforcing Injective as the leading institutional-friendly Layer 1 network.Here is why this is a big deal 👇 8:30 pm · 27 Feb 2025 219 Reply Copy link Read 18 replies Validators like MMS ensure the reliability of Injective’s offerings, which include digital asset trading, tokenization, lending, and payments. MMS joins an elite group of validators, including players from banking, finance, and tech. Together, they participate in Injective’s on-chain governance. Notably, Deutsche Telekom is no small player. With a market cap exceeding $180 billion, it serves over 252 million mobile customers worldwide. The company operates in more than 50 countries and generated 112 billion Euros in revenue in 2023, and its subsidiary MMS joining Injective’s validator set brings significant credibility to the blockchain. Injective’s CEO, Eric Chen, praised the partnership, calling it a thrilling moment to work with a global telecommunications leader. Chen emphasized that this step reflects Web3’s growing institutional adoption. He believes decentralized blockchains offer unmatched reliability and security, especially for financial applications. Oliver Nyderle, Head of Digital Trust and Web3 Infrastructure at Deutsche Telekom MMS, echoed this sentiment. He said the collaboration boosts true decentralization and enhances security for users. Nyderle added that it aligns with MMS’s mission to merge technology with safety and trust. The company sees this as a way to drive secure progress in the digital age. The timing of this announcement is noteworthy. Injective recently rolled out its Nivara Mainnet Upgrade. This update introduced a modernized architecture for real-world asset (RWA) tokenization. It also included enhancements tailored for institutional use. With Deutsche Telekom’s enterprise infrastructure, Injective now has a stronger foundation to attract traditional finance players. Backed by Binance, Jump Crypto, Pantera, and Mark Cuban, Injective is a top Layer-1 blockchain. The network has processed over 1 billion on-chain transactions so far. According to DeFiLlama, Injective’s total value locked (TVL) sits at $39.48 million, with a 24-hour volume of $4.18 million as of now. Its native INJ coin trades at $13.76, up 1%. Also, this is not the first time Deutsche Telekom is becoming a validator for a blockchain network. In November 2023, MMS became a validator for Aleph Zero, a privacy-focused blockchain. By June 2023, it hosted over 60 million euros in assets from projects like Chainlink, Ethereum, and Polkadot. Dirk Röder, Head of MMS’s Web3 Infrastructure and Solutions Team, has also hinted at more developments to come, saying that the company is actively exploring new blockchain initiatives. The post Deutsche Telekom’s subsidiary MMS becomes an Injective Network validator appeared first on Invezz
